Phagenesis
Series D+Phagenesis raised €39M in a Series D+ round in Mar 2024. The company is based in Manchester Science Park Pencroft, UK. Investors in the round: Aphelion, British Patient Capital, EQT Life Sciences and 2 others. Data as of Nov 2026.
Amount raised
€39M
€38,723,954
Native amount
42,000,000 USD
Stage
Series D+
series d
Investors
5
Provenance & confidence
High confidenceAmount
42,000,000 USD
ECB-at-date → €39M · rate 1.0846 on 2024-03-04
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedDate
Mar 2024
Round type
series d
Amount (EUR)
€39M